冠心病二级预防用药出院带药情况分析  

Analysis on Prescribed Medications for Discharged Patients in Secondary Prevention of Coronary Heart Disease

作　　者：马丽[1] 

机构地区：[1]张掖医学高等专科学校,甘肃张掖734000

出　　处：《西部中医药》2013年第7期58-60,共3页Western Journal of Traditional Chinese Medicine

摘　　要：目的:通过调查冠心病(CHD)患者出院带药情况,了解CHD二级预防药物的使用情况。方法:对张掖市人民医院近3年296例CHD患者出院带药情况(主要为二级预防药物)进行回顾性分析。结果:296例CHD患者中266例有出院带药记录。出院带药情况为:抗血小板药(97.7%)、他汀类药物(87.7%)、β受体阻断剂(71.4%)、血管紧张素转换酶抑制剂(ACEI)/血管紧张素受体拮抗剂(ARB)(64.3%),平均带药种类为(3.25±0.8)种。结论:从CHD二级预防药物出院带药率情况来看,该院医生对CHD二级预防非常重视,但存在指导用药不规范的问题,抗血小板药、他汀类药物带药率高,β受体阻断剂、ACEI/ARB带药率较低。Objective： To know the conditions of secondary prevention medicine through surveying the prescribed medications for discharged patients with coronary heart disease （CHD）. Method： The prescribed medications （mainly secondary prevention medicine） for 296 patients discharged from people＇s hospital of Zhangye in recent three years were retrospectively analyzed. Result： There were 266 patients with the records of prescribed medications when discharged among 296 patients. The conditions were： antiplatclet drugs （97.7%）, statins （87.7%）, receptor blocker（71.4%）, ACEI/ARB（64.3%）, average types of drugs （3.25±0.80）. Conclusion： Doctors emphasize secondary prevention of CHD from the conditions of prescribed medications when CHD patients were discharged, but the prescribed medications are confused and need to be improved, antiplatelet drugs and statins are prescribed more when CHD patients were discharged, while β receptor blocker and ACEI/ARB are prescribed less.

关 键 词：冠心病 二级预防 出院带药 调查分析 

分 类 号：R541.4[医药卫生—心血管疾病]